Sarclisa Interactions
There are 241 drugs known to interact with Sarclisa (isatuximab), along with 1 disease interaction. Of the total drug interactions, 50 are major, and 191 are moderate.
- View all 241 medications that may interact with Sarclisa
- View Sarclisa disease interactions (1)
Most frequently checked interactions
View interaction reports for Sarclisa (isatuximab) and the medicines listed below.
- alpha-lipoic acid
- Ampyra (dalfampridine)
- Braftovi (encorafenib)
- Campath (alemtuzumab)
- Cytosar (cytarabine)
- Decadron (dexamethasone)
- dicyclomine
- doxylamine
- Eloxatin (oxaliplatin)
- Epogen (epoetin alfa)
- Erbitux (cetuximab)
- Fludara (fludarabine)
- idarubicin
- Imbruvica (ibrutinib)
- immune globulin oral
- irinotecan
- ivermectin
- Kyprolis (carfilzomib)
- Mektovi (binimetinib)
- melphalan
- Peganone (ethotoin)
- pegfilgrastim
- pirfenidone
- Pomalyst (pomalidomide)
- pyridoxine
- Rebinyn (coagulation factor ix)
- Rituxan Hycela (hyaluronidase / rituximab)
- solifenacin
- Tarceva (erlotinib)
- Tecfidera (dimethyl fumarate)
Sarclisa disease interactions
There is 1 disease interaction with Sarclisa (isatuximab) which include:
Report options
More about Sarclisa (isatuximab)
- Sarclisa consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CD38 monoclonal antibodies
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Abecma
Abecma is a CAR T cell therapy used to treat relapsed refractory multiple myeloma (RRMM); it is a ...
Tecvayli
Tecvayli (teclistamab) is a treatment for relapsed or refractory multiple myeloma. Includes ...
Carvykti
Carvykti (ciltacabtagene autoleucel) is a treatment for relapsed or refractory multiple myeloma ...
Talvey
Talvey is used to treat relapsed or refractory multiple myeloma. Includes Talvey side effects ...
Decadron
Decadron is used for addison's disease, adrenal insufficiency, adrenocortical insufficiency ...
Revlimid
Revlimid is used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma and ...
Darzalex
Darzalex (daratumumab) is a target therapy used to treat multiple myeloma. Includes DARZALEX uses ...
Velcade
Velcade injection is used to treat multiple myeloma and mantle cell lymphoma. Includes Velcade side ...
Pomalyst
Pomalyst (pomalidomide) is used to treat multiple myeloma and AIDS-related Kaposi sarcoma. Includes ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
